ALC-0315
Recommended because it shares a closely related research category or delivery context. Formulation and performance are product- and study-specific.
View product →
Ionizable lipid for LNP and nucleic-acid delivery research.
C12-TLRa is an adjuvant lipidoid. C12-TLRa substitution can enhance the immunogenicity of clinically relevant SARS-CoV-2 mRNA-LNP vaccines, which holds translational potential.
| CAS No. | Not available |
| Chemical Name | C12-TLRa |
| Synonyms | C12TLRa, C12 TLRa |
| SMILES | NC1=NC2=CC=CC=C2C3=C1N=C(CCCC)N3CC4=CC=C(CN(CC(O)CCCCCCCCCC)CC(O)CCCCCCCCCC)C=C4 |
| Formula | C46H73N5O2 |
| M.Wt | 728.10 |
| Purity | >98% |
| Storage | Pure form: −20 °C, 1 year; In solvent: −80 °C, 6 months; −20 °C, 1 month. Sealed and protected from light. |
| Shipping condition | Ships from Shanghai. Pure lipid is stable during ice-pack transport. |
| Publication | Not available |
The product molecular weight is prefilled when available and remains editable. Confirm solvent compatibility and solubility before preparation.
Solvent volumes update from the molecular weight above.
| Mass | 1 mM | 5 mM | 10 mM |
|---|---|---|---|
| 10 mg | 13.7344 mL | 2.7469 mL | 1.3734 mL |
| 25 mg | 34.3359 mL | 6.8672 mL | 3.4336 mL |
| 50 mg | 68.6719 mL | 13.7344 mL | 6.8672 mL |
| 100 mg | 137.3438 mL | 27.4688 mL | 13.7344 mL |
| 250 mg | 343.3594 mL | 68.6719 mL | 34.3359 mL |
Contact our team with the catalog number and requested quantity.